The recent New York Times' article on peripheral vascular stenting created a lot of debate within the vascular community with approving and dissenting opinions.

My colleague, Louise, and I believe the claims made by the article are not supported by Medicare data. The following video outlines our concerns with the article and provides our analysis of Medicare-based vascular treatment rates, intervention types, physician specialty involvement, and office-based care that together, refute the claims of the article.

Pivoting a product launch during the pandemic

View Now